<DOC>
	<DOC>NCT00200902</DOC>
	<brief_summary>This study will use measurements of depression symptoms and brain activity to determine what factors may influence an individual's response to treatment for depression.</brief_summary>
	<brief_title>Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression</brief_title>
	<detailed_description>We are using depression symptom measurements and measurements of brain electrical activity (EEG) to determine what factors may influence whether a patient is likely to show a response to antidepressant medication, placebo, or only clinical visits (without the use of pills) during a treatment trial for depression.</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Clinical diagnosis of unipolar major depression Substance abuse Psychotic disorder History of severe head trauma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Major depressive disorder</keyword>
	<keyword>MDD</keyword>
	<keyword>Antidepressant</keyword>
</DOC>